Neurologic, Neurocognitive, and Brain Growth Outcomes in Human Immunodeficiency Virus-Infected Children Receiving Different Nucleoside Antiretroviral Regimens
- 1 September 1999
- journal article
- conference paper
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 104 (3) , e32
- https://doi.org/10.1542/peds.104.3.e32
Abstract
Objectives. To compare the impact of three different nucleoside reverse transcriptase inhibitor regimens, zidovudine (ZDV) monotherapy, didanosine (ddI) monotherapy, and ZDV plus ddI combination therapy, on central nervous system (CNS) outcomes in symptomatic human immunodeficiency virus (HIV)-infected children. Methods. Serial neurologic examinations, neurocognitive tests, and brain growth assessments (head circumference measurements and head computed tomography or magnetic resonance imaging studies) were performed in 831 infants and children who participated in a randomized double-blind clinical trial of nucleoside reverse transcriptase inhibitors. The Pediatric AIDS Clinical Trials Group study 152 conducted between 1991 and 1995 enrolled antiretroviral therapy-naive children. Subjects were stratified by age (3 to <30 months of age or 30 months to 18 years of age) and randomized in equal proportions to the three treatment groups. Results. Combination ZDV and ddI therapy was superior to either ZDV or ddI monotherapy for most of the CNS outcomes evaluated. Treatment differences were observed within both age strata. ZDV monotherapy showed a modest statistically significant improvement in cognitive performance compared with ddI monotherapy during the initial 24 weeks, but for subsequent protection against CNS deterioration no clear difference was observed between the two monotherapy arms. Conclusions. Combination therapy with ZDV and ddI was more effective than either of the two monotherapies against CNS manifestations of human immunodeficiency virus disease. The results of this study did not indicate a long-term beneficial effect for ZDV monotherapy compared with ddI monotherapy.Keywords
This publication has 39 references indexed in Scilit:
- Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infectionThe Journal of Pediatrics, 1998
- Encephalopathy in children with perinatally acquired human immunodeficiency virus infectionThe Journal of Pediatrics, 1995
- Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.Journal of Clinical Investigation, 1993
- A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus DiseaseNew England Journal of Medicine, 1991
- Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infectionThe Journal of Pediatrics, 1990
- Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infectionThe Journal of Pediatrics, 1990
- Neuropsychological Outcome of Zidovudine (AZT) Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1988
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986